Non-invasive imaging: Use of cardiovascular magnetic resonance imaging in the assessment of left ventricular function, scar and viability in patients with ischaemic cardiomyopathy and chronic myocardial infarction

Heart

Volumn 96, Issue 18, 2010, Pages 1494-1501

  Beek, A M ^a   Van Rossum, A C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18;

ANEURYSM; ARTERIAL WALL THICKNESS; ARTERY OCCLUSION; ARTERY THROMBOSIS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; DEFIBRILLATOR; DEVICE THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; LOW DRUG DOSE; MYOCARDIAL HIBERNATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; ARTICLE; HEART MUSCLE ISCHEMIA; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SCAR;

CICATRIX; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROGNOSIS; VENTRICULAR FUNCTION, LEFT;

EID: 77957103961     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.181123     Document Type: Review

References (40)

1. Larose E, Ganz P, Reynolds HG, et al. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 2007;49:855-62. (Pubitemid 46298799)
2. Lloyd SG, Buckberg GD. Use of cardiac magnetic resonance imaging in surgical ventricular restoration. Eur J Cardiothorac Surg 2006;29(Suppl 1):S216-24.
3. Nijveldt R, Marcu CB, van Rossum AC. Lipomatous metaplasia in myocardial infarction detected by cardiovascular magnetic resonance. Heart 2006;92:1337.
4. Baroldi G, Silver MD, De Maria R, et al. Lipomatous metaplasia in left ventricular scar. Can J Cardiol 1997;13:65-71. (Pubitemid 27087140)
5. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002. Landmark paper that set the stage for delayed contrast enhanced CMR.
6. Nijveldt R, Beek AM, Hofman MB, et al. Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction. J Cardiovasc Magn Reson 2007;9:765-70. (Pubitemid 47463905)
7. Ertl G, Frantz S. Healing after myocardial infarction. Cardiovasc Res 2005;66:22-32.
8. Moon JC, De Arenaza DP, Elkington AG, et al. The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. J Am Coll Cardiol 2004;44:554-60. This paper clarifies the relation between the Q wave/non-Q wave ECG classification of myocardial infarction and infarct extent according to DE imaging.
9. Asch FM, Shah S, Rattin C, et al. Lack of sensitivity of the electrocardiogram for detection of old myocardial infarction: a cardiac magnetic resonance imaging study. Am Heart J 2006;152:742-8. (Pubitemid 44396885)
10. Bayes DL, Cino JM, Pujadas S, et al. Concordance of electrocardiographic patterns and healed myocardial infarction location detected by cardiovascular magnetic resonance. Am J Cardiol 2006;97:443-51. (Pubitemid 43190029)
11. Soriano CJ, Ridocci F, Estornell J, et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 2005;45:743-8. This paper shows the feasibility of DE imaging to differentiate between ischaemic and non-ischaemic causes of cardiomyopathy.
12. Mahrholdt H, Wagner A, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-74. Excellent review on the DE contrast patterns seen in ischaemic and non-ischaemic cardiomyopathies.
13. Kwong RY, Chan AK, Brown KA, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-43. This paper demonstrates that the finding of regional myocardial scar in patients with suspected ischaemic heart disease has prognostic relevance.
14. Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007;115:2006-14.
15. Yan AT, Shayne AJ, Brown KA, et al. Characterization of the periinfarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006;114:32-9.
16. Bogun F, Desjardins B, Crawford T, et al. Post-infarction ventricular arrhythmias originating in papillary muscles. J Am Coll Cardiol 2008;51:1794-802. (Pubitemid 351608500)
17. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8. (Pubitemid 34267418)
18. Selvanayagam JB, Jerosch-Herold M, Porto I, et al. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation 2005;112:3289-96. (Pubitemid 43739374)
19. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998;31:1040-8. (Pubitemid 28212504)
20. Schinkel AF, Bax JJ, Boersma E, et al. Assessment of residual myocardial viability in regions with chronic electrocardiographic Q-wave infarction. Am Heart J 2002;144:865-9. (Pubitemid 35335180)
21. Kim RJ, Shah DJ. Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough. Heart 2004;90:137-40.
22. Baer FM, Theissen P, Crnac J, et al. Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 2000;21:981-91.
23. Cigarroa CG, deFilippi CR, Brickner ME, et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.
24. Schinkel AFL, Bax JJ, Poldermans D, et al. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 2007;32:375-410.
25. Perrone-Filardi P, Pace L, Prastaro M, et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography. Circulation 1996;94:2712-19.
26. Afridi I, Kleiman NS, Raizner AE, et al. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
27. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53. The first study to demonstrate the potential of DE imaging to predict functional recovery of hibernating myocardium after revascularisation.
28. Kuhl HP, Beek AM, van der Weerdt AP, et al. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003;41:1341-8.
29. Kuhl HP, Lipke CS, Krombach GA, et al. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Eur Heart J 2006;27:846-53.
30. 201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease. J Nucl Med 2007;48:1096-103.
31. Knuesel PR, Nanz D, Wyss C, et al. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 2003;108:1095-100.
32. Kaandorp TAM, Bax JJ, Schuijf JD, et al. Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy. Am J Cardiol 2004;93:1461-4.
33. Bove CM, DiMaria JM, Voros S, et al. Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting - initial experience. Radiology 2006;240:835-41. (Pubitemid 44267342)
34. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004;109:2172-4. (Pubitemid 38625392)
35. Bondarenko O, Beek AM, Nijveldt R, et al. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis. J Cardiovasc Magn Reson 2007;9:815-21. (Pubitemid 47463906)
36. Bondarenko O, Beek AM, Twisk JW, et al. Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study. Eur Heart J 2008;29:2000-5. This study demonstrated that the time course of functional improvement of hibernating myocardium after revascularisation can be considerably protracted, and that both likelihood and time course are predicted by the segmental extent of hyperenhancement.
37. Bilchick KC, Dimaano V, Wu KC, et al. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging 2008;1:561-8.
38. Koos R, Neizel M, Schummers G, et al. Feasibility and initial experience of assessment of mechanical dyssynchrony using cardiovascular magnetic resonance and semi-automatic border detection. J Cardiovasc Magn Reson 2008;10:49.
39. Bleeker GB, Kaandorp TAM, Lamb HJ, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76.
40. White JA, Yee R, Yuan X, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006;48:1953-60. (Pubitemid 44738444)